Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05750381

Assessment of Colonisation and Skin Quality Parameter Improvement by Probiotic Micrococcus Luteus Q24 Balm in Healthy Adults.

Conditions: Microbial Colonization

Sex: All
Ages: 18 Years – 80 Years
Healthy volunteers: 1
Phase: NA
Enrollment: 20
Sponsor: BLIS Technologies Limited

Location: New Zealand

Summary

The purpose of this study is to evaluate the skin quality improvement and colonization efficacy following the application of probiotic Micrococcus luteus Q24 (BLIS Q24) to the elbow and back of forearm in a topical balm format in healthy adults.

Eligibility Criteria

Inclusion Criteria:In general good health 18 - 80 years of age.Practice good general body hygieneExclusion Criteria:Have a history of autoimmune disease or are immunocompromised.Are on concurrent antibiotic therapy or regular antibiotic use within the last 1 week.People with allergies or sensitivity to dairy.People with an open wound on the Blis Q24 application sites.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05750381). StuddyBuddy aggregates publicly available trial information.